ABIOMED/ US0036541003 /
| 2022-12-21 9:59:52 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 381.19USD | - | 346,755 Turnover: 132.07 mill. |
-Bid Size: - | -Ask Size: - | 17.18 bill.USD | - | 127.01 |
Assets
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 6.5000 | 6.8890 | 9.1270 | 23.1840 | 87.7770 | ||||||
| Intangible Assets | 0.0000 | - | - | - | - | ||||||
| Long-Term Investments | - | 41.7610 | 13.9960 | 1 | 47.1430 | ||||||
| Fixed Assets | - | 87.4410 | 118.2280 | 135.5390 | 223.4560 | ||||||
| Inventories | 14.9000 | 13.9480 | 16.7740 | 26.7400 | 34.9310 | ||||||
| Accounts Receivable | 22.9000 | 24.3570 | 31.8280 | 42.8210 | 54.0550 | ||||||
| Cash and Cash Equivalents | 9.5000 | 20.9160 | 22.4010 | 48.2310 | 39.0400 | ||||||
| Current Assets | 116.6000 | 117.9660 | 220.1390 | 288.3920 | 326.9580 | ||||||
| Total Assets | 170 | 205.4070 | 338.3670 | 423.9310 | 550.4140 | ||||||
Liabilities
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 7.7000 | 7.7460 | 10.3890 | 9.3810 | 20.6200 | ||||||
| Long-term debt | - | - | - | - | 15.5390 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 5.6000 | 6.4000 | .8000 | .8000 | 16.3000 | ||||||
| Liabilities | 32.9000 | 37.0540 | 46.8070 | 55.1560 | 98.3430 | ||||||
| Share Capital | - | .4110 | .4130 | .4260 | .4370 | ||||||
| Total Equity | 137.1000 | 168.3530 | 291.5600 | 368.7750 | 452.0710 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 170 | 205.4070 | 338.3670 | 423.9310 | 550.4140 | ||||||
Income Statement
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 158.1000 | 183.6430 | 230.3110 | 329.5430 | 445.3040 | ||||||
| Depreciation (total) | .1000 | 2.5080 | 2.7700 | 3.2770 | 6.2020 | ||||||
| Operating Result | 16.5000 | 8.3630 | 28.6660 | 65.1040 | 90.1380 | ||||||
| Interest Income | - | .1180 | .1960 | .3950 | 1.5540 | ||||||
| Income Before Taxes | 16.9000 | 8.5300 | 28.7650 | 65.8380 | 91.3430 | ||||||
| Income Taxes | 1.8000 | 1.1790 | -84.9230 | 27.6910 | 39.2270 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 15 | 7.3510 | 113.6880 | 38.1470 | 52.1160 | ||||||
Per Share
Cash Flow
| 2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 26.4000 | 23.4660 | 43.2900 | 76.7950 | 115.1160 | ||||||
| Cash Flow from Investing Activities | -10.3000 | -22.2720 | -49.8630 | -57.7100 | -126.3330 | ||||||
| Cash Flow from Financing | -11.8000 | 9.6320 | 9.5230 | 7.1600 | 3.8670 | ||||||
| Decrease / Increase in Cash | 3.5000 | 11.4650 | 1.4850 | 25.8300 | -9.1910 | ||||||
| Employees | 467 | 511 | 589 | 747 | 908 | ||||||
